# Characterizing the formation and maintenance of drug-biased beliefs in opioid use disorder

> **NIH NIH F31** · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · 2024 · $44,036

## Abstract

PROJECT SUMMARY/ABSTRACT
Despite psychoeducational efforts highlighting consequences of opioid use, relapse remains common for
individuals with opioid use disorder (OUD). This clinical observation indicates a need for better understanding
how undesirable information about drug use is evaluated and incorporated into patient’s beliefs about personal
risk. People hold biased beliefs about their personal risk in various life domains, expecting more good outcomes
to happen to them than bad outcomes. This “optimism bias” can be explained by a biased belief updating process
that weighs better-than-expected past outcomes more heavily than worse-than-expected past outcomes when
forming future expectations. This “optimism bias” could explain mechanisms that drive opioid use despite well-
recognized risks for harm. Such biased beliefs in OUD have primarily been studied using self-report measures.
Additionally, neuroimaging work on these biases has been restricted to healthy individuals. The psychological
and neural determinants of these biases as they relate to drug use in OUD remain unknown. I propose to, for
the first time, quantify domain-specific optimism biases in OUD and to re-assess these biases as participants
engage with their daily life outside of the lab. Here, I will study the behavioral, neural, and longitudinal
mechanisms of biased beliefs in treatment-seeking individuals with OUD and matched healthy controls. Using a
neurocomputational framework, during functional magnetic resonance imaging (fMRI), subjects will estimate
their likelihood of drug- and nondrug-related negative events occurring to them (e.g., overdose, bone fracture).
They will then be shown the true base rate of these negative events and will be given the opportunity to update
their estimates. In Aim 1, I will use this approach to test whether opioid users underestimate their likelihood for
negative events and whether they would update their beliefs more after receiving better-than expected vs. worse-
than-expected information, especially when outcomes are related to their drug use. To test how biased belief
updating emerges in the brain, in Aim 2, I will record brain activity during the initial estimation and updating period
of the task in Aim 1, which I hypothesize to involve cortico-limbic-striatal circuitry centered on the inferior frontal
gyrus and ventral striatum. Following the MRI session, in Aim 3, subjects will be enrolled in a 4-week ecological
momentary assessment (EMA) study and complete an abridged version of the optimism bias task to determine
the maintenance and durability of domain-specific optimistic beliefs. The proposed Diversity-F31 training and
research plan will support the formal training I will receive in my doctoral program by: (1) increasing my
knowledge in human addiction neuroscience; (2) increasing proficiency in methods and concepts in cognitive
neuroscience and advanced neuroimaging techniques; and (3) developing training in advanced multi-level
...

## Key facts

- **NIH application ID:** 10826771
- **Project number:** 1F31DA058497-01A1
- **Recipient organization:** RUTGERS BIOMEDICAL AND HEALTH SCIENCES
- **Principal Investigator:** Emmanuel Eduardo Alvarez
- **Activity code:** F31 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $44,036
- **Award type:** 1
- **Project period:** 2024-02-14 → 2026-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10826771

## Citation

> US National Institutes of Health, RePORTER application 10826771, Characterizing the formation and maintenance of drug-biased beliefs in opioid use disorder (1F31DA058497-01A1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10826771. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
